Tag Archives: biosimilar substitution

100 advocacy state victories

100 State Advocacy Victories….and Counting!

The Arthritis Foundation reached a milestone in September, securing our 100th state legislative victory since 2014! Congratulations Advocates!! All of these victories were made possible due to all of you!

Our victories occurred in 47 states plus Washington, DC, impacting more than 50 million people with doctor-diagnosed arthritis, and have focused on many patient access to care issues like:

Continue reading 100 State Advocacy Victories….and Counting!

biosimilars substitution victory

Biosimilar Substitution Victories Across the Country!

The Arthritis Foundation thanks the governors in eight states for signing biosimilar legislation in 2018 that enhances patient access to new and innovative medications, while ensuring that pharmacists are communicating critical, up-to-date medical information about patients to physicians. New laws in Connecticut, Michigan, New Hampshire, South Dakota, Vermont, Wyoming, West Virginia and Wisconsin will positively impact approximately 5.3 million people with doctor-diagnosed arthritis.

“This legislation will grant access to life-changing medications while ensuring proper safeguards for both patient and physician when a prescription is substituted,” said Connecticut Advocacy Chair Paula Haney.

Continue reading Biosimilar Substitution Victories Across the Country!

Arthritis Biosimilars Pennsylvania

Pennsylvania Arthritis Advocates Achieve Biosimilar Substitution Success!

Devon SalasinDevon Salasin is a junior at Penn State University and a talented snow skier. So good, that she recently placed 23rd out of 107 skiers at the National Collegiate Alpine Race. But skiing wasn’t always fun or easy for Devon.

In 2011, Devon was diagnosed with juvenile rheumatoid arthritis (JRA). Overnight she went from a carefree kid pursuing her snow ski racing passion to a kid burdened with pain, swollen and deteriorating joints, and fatigue.
Continue reading Pennsylvania Arthritis Advocates Achieve Biosimilar Substitution Success!